NCT02173912 - Bioequivalence Study of CJ-30059 | Biotech Hunter

Enrollment

32

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference)

"Sequence 1 receives Candesartan cilexetil 16 mg and Amlodipine besylate 10mg first, then CJ-30059 second, with at least 14-day wash-out period in between.~Sequence 2 receives CJ-30059 first, then Candesartan cilexetil 16 mg and Amlodipine besylate 10mg second, with at least 14-day wash-out period in between."

DRUG

CJ-30059 (Test)

"Sequence 1 receives Candesartan cilexetil 16 mg and Amlodipine besylate 10mg first, then CJ-30059 second, with at least 14-day wash-out period in between.~Sequence 2 receives CJ-30059 first, then Candesartan cilexetil 16 mg and Amlodipine besylate 10mg second, with at least 14-day wash-out period in between."

Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul